Literature DB >> 35378026

Bile Acids Are Important Contributors to AKI Associated with Liver Disease: PRO.

Peter Fickert1, Alexander R Rosenkranz2.   

Abstract

Entities:  

Keywords:  acute kidney injury; acute kidney injury and ICU nephrology; bile acids; hepatorenal syndrome; liver failure

Mesh：

Substances：

Year:  2021        PMID： 35378026      PMCID： PMC8967615          DOI： 10.34067/KID.0005932020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  22 in total

1.  Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis.

Authors:  Thomas Horvatits; Andreas Drolz; Kevin Roedl; Karoline Rutter; Arnulf Ferlitsch; Günter Fauler; Michael Trauner; Valentin Fuhrmann
Journal:  Liver Int       Date:  2016-08-04       Impact factor: 5.828

2.  Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections.

Authors:  Rogelio Barreto; Chiara Elia; Elsa Solà; Rebeca Moreira; Xavier Ariza; Ezequiel Rodríguez; Isabel Graupera; Ignacio Alfaro; Manuel Morales-Ruiz; Estaban Poch; Mónica Guevara; Javier Fernández; Wladimiro Jiménez; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2014-03-05       Impact factor: 25.083

3.  Cholemic Nephropathy Causes Acute Kidney Injury and Is Accompanied by Loss of Aquaporin 2 in Collecting Ducts.

Authors:  Jan Hinrich Bräsen; Young-Seon Mederacke; Jessica Schmitz; Kateryna Diahovets; Abedalrazag Khalifa; Björn Hartleben; Fermín Person; Thorsten Wiech; Eric Steenbergen; Anika Großhennig; Michael P Manns; Roland Schmitt; Ingmar Mederacke
Journal:  Hepatology       Date:  2019-03-14       Impact factor: 17.425

Review 4.  Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.

Authors:  Juan Carlos Q Velez; George Therapondos; Luis A Juncos
Journal:  Nat Rev Nephrol       Date:  2019-11-13       Impact factor: 28.314

Review 5.  Bile acid receptors and the kidney.

Authors:  Michal Herman-Edelstein; Talia Weinstein; Moshe Levi
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-01       Impact factor: 2.894

6.  Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.

Authors:  Florence Wong; S Chris Pappas; Michael P Curry; K Rajender Reddy; Raymond A Rubin; Michael K Porayko; Stevan A Gonzalez; Khalid Mumtaz; Nicholas Lim; Douglas A Simonetto; Pratima Sharma; Arun J Sanyal; Marlyn J Mayo; R Todd Frederick; Shannon Escalante; Khurram Jamil
Journal:  N Engl J Med       Date:  2021-03-04       Impact factor: 91.245

7.  Hepatorenal Syndrome.

Authors:  Claire Francoz; François Durand; Jeffrey A Kahn; Yuri S Genyk; Mitra K Nadim
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-17       Impact factor: 8.237

8.  Vasoactive effects of bile salts in cirrhotic rats: in vivo and in vitro studies.

Authors:  J M Pak; S S Lee
Journal:  Hepatology       Date:  1993-11       Impact factor: 17.425

9.  Bile Cast Nephropathy in Cirrhotic Patients: Effects of Chronic Hyperbilirubinemia.

Authors:  Michelle Foshat; Heather M Ruff; Wayne G Fischer; Robert E Beach; Mark R Fowler; Hyunsu Ju; Judith F Aronson; Marjan Afrouzian
Journal:  Am J Clin Pathol       Date:  2017-05-01       Impact factor: 2.493

10.  Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy Study.

Authors:  Suman Lata Nayak; Manoj Kumar; Chhagan Bihari; Archana Rastogi
Journal:  J Clin Transl Hepatol       Date:  2017-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.